CDH2 and hepatocellular carcinoma: This study demonstrated that HCC cells with lower TMEM106A expression showed higher expressions of Vimentin and N-cadherin and lower expressions of E-cadherin, indicating that TMEM106A may be an effective EMT inhibitor which contributes to less invasiveness and metastasis of HCC cells.